{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:09:31Z","timestamp":1788808171196,"version":"build-2803163510"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Excellent Youth Talents of Health Science and Technology Innovation of Henan Province","award":["YQRC2023020"],"award-info":[{"award-number":["YQRC2023020"]}]},{"name":"Key project of Henan Natural Science Foundation","award":["242300421195"],"award-info":[{"award-number":["242300421195"]}]},{"name":"Henan Province Young and Middle-aged Health Science and Technology Innovation Outstanding Young Talents Project","award":["JQRC2024010"],"award-info":[{"award-number":["JQRC2024010"]}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["262102311049"],"award-info":[{"award-number":["262102311049"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This review starts with the historical background and biological features to classify mainly the liquid biopsy biomarkers, such as circulating tumor DNA, circulating tumor cells, extracellular vesicles, non-coding RNAs, tumor-educated platelets and tumor-associated antigens, and also summarizes the present classification approaches and advanced detection techniques for each biomarker type. On this basis, the potential clinical uses of liquid biopsy in oncology are discussed in detail, including the early cancer detection, the prediction of the responses to chemotherapy, radiotherapy and immunotherapy, the evaluation of the treatment effects, the monitoring of the residual diseases and the investigation into the tumor heterogeneity and the resistance mechanisms. Moreover, the discussion is extended to other non-oncological fields, involving the reproduction medicine, the transplantation medicine, the neurological disorders, the infectious diseases and various chronic diseases such as the metabolic dysfunction-related liver disease and fibrosis, pulmonary fibrosis, lupus nephritis and renal fibrosis as well as rheumatoid arthritis. Finally, based on the comprehensive summary given above, this review summarizes the current status of the research on liquid biopsy, points out the main obstacles which hinder its wide application in clinic, for example, the absence of standard procedures and the necessity of large-scale prospective validation, and suggests possible future trends like the integration of multi-omics, the use of artificial intelligence in the analysis and the approach towards routine clinical practice.<\/jats:p>","DOI":"10.1186\/s43556-026-00533-1","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:36:32Z","timestamp":1788762992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liquid biopsy: current applications and future directions"],"prefix":"10.1186","volume":"7","author":[{"given":"Yunxiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8446-6987","authenticated-orcid":false,"given":"Liwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"3\u20134","key":"533_CR1","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel P. Metais P [Nuclear Acids In Human Blood Plasma]. C R Seances Soc Biol Fil. 1948;142(3\u20134):241\u20133.","journal-title":"C R Seances Soc Biol Fil"},{"issue":"3","key":"533_CR2","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM. Yaros MJ Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(3):646\u201350.","journal-title":"Cancer Res"},{"issue":"1","key":"533_CR3","first-page":"67","volume":"3","author":"GD Sorenson","year":"1994","unstructured":"Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ. Yao SL Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev. 1994;3(1):67\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"533_CR4","unstructured":"Ashworth T A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869;14:146."},{"issue":"19","key":"533_CR5","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412\u201320.","journal-title":"J Biol Chem"},{"issue":"5","key":"533_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843\u201354. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-y.","journal-title":"Cell"},{"issue":"6772","key":"533_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/35002607","volume":"403","author":"BJ Reinhart","year":"2000","unstructured":"Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901\u20136. https:\/\/doi.org\/10.1038\/35002607.","journal-title":"Nature"},{"key":"533_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-0716-2950-5_8","volume":"2621","author":"K Maurer","year":"2023","unstructured":"Maurer K. Schandl CA Liquid Biopsy for Advanced Cancer: An Amplicon-Based Massively Parallel Sequencing Panel Approach to Precision Oncology. Methods Mol Biol. 2023;2621:111\u201326. https:\/\/doi.org\/10.1007\/978-1-0716-2950-5_8.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"533_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","volume":"35","author":"AR Thierry","year":"2016","unstructured":"Thierry AR, El Messaoudi S, Gahan PB, Anker P. Stroun M Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016;35(3):347\u201376. https:\/\/doi.org\/10.1007\/s10555-016-9629-x.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"533_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1365-2141.1994.tb04828.x","volume":"86","author":"V Vasioukhin","year":"1994","unstructured":"Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C. Stroun M Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol. 1994;86(4):774\u20139. https:\/\/doi.org\/10.1111\/j.1365-2141.1994.tb04828.x.","journal-title":"Br J Haematol"},{"issue":"12","key":"533_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.Cd-17-0716","volume":"7","author":"AA Chaudhuri","year":"2017","unstructured":"Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. Cancer Discov. 2017;7(12):1394\u2013403. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0716.","journal-title":"Cancer Discov"},{"issue":"1","key":"533_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17316-z","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Gole J, Gore A, He Q, Lu M, Min J, et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat Commun. 2020;11(1):3475. https:\/\/doi.org\/10.1038\/s41467-020-17316-z.","journal-title":"Nat Commun"},{"issue":"1","key":"533_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41467-018-03215-x","volume":"9","author":"B O'Leary","year":"2018","unstructured":"O\u2019Leary B, Hrebien S, Morden JP, Beaney M, Fribbens C, Huang X, et al. Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer. Nat Commun. 2018;9(1):896. https:\/\/doi.org\/10.1038\/s41467-018-03215-x.","journal-title":"Nat Commun"},{"key":"533_CR14","first-page":"1","volume":"201","author":"HC Engell","year":"1955","unstructured":"Engell HC. Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl. 1955;201:1\u201370.","journal-title":"Acta Chir Scand Suppl"},{"issue":"3","key":"533_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archsurg.1958.01280210004002","volume":"76","author":"S Roberts","year":"1958","unstructured":"Roberts S, Watne A, Mc GR, Mc GE. Cole WH Technique and results of isolation of cancer cells from the circulating blood. AMA Arch Surg. 1958;76(3):334\u201346. https:\/\/doi.org\/10.1001\/archsurg.1958.01280210004002.","journal-title":"AMA Arch Surg"},{"key":"533_CR16","first-page":"169","volume":"9","author":"WMCANCERCELLSINTHEPERIPHERALBLOOD Christopherson","year":"1965","unstructured":"Christopherson WMCANCERCELLSINTHEPERIPHERALBLOOD. A SECOND LOOK Acta Cytol. 1965;9:169\u201374.","journal-title":"A SECOND LOOK Acta Cytol"},{"issue":"8","key":"533_CR17","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1073\/pnas.95.8.4589","volume":"95","author":"E Racila","year":"1998","unstructured":"Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW. Uhr JW Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A. 1998;95(8):4589\u201394. https:\/\/doi.org\/10.1073\/pnas.95.8.4589.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"533_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1373\/clinchem.2012.194258","volume":"59","author":"C Alix-Panabi\u00e8res","year":"2013","unstructured":"Alix-Panabi\u00e8res C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2013;59(1):110\u20138. https:\/\/doi.org\/10.1373\/clinchem.2012.194258.","journal-title":"Clin Chem"},{"issue":"8","key":"533_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781\u201391. https:\/\/doi.org\/10.1056\/NEJMoa040766.","journal-title":"N Engl J Med"},{"issue":"19","key":"533_CR20","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1200\/jco.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(19):3213\u201321. https:\/\/doi.org\/10.1200\/jco.2007.15.8923.","journal-title":"J Clin Oncol"},{"issue":"19","key":"533_CR21","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1158\/1078-0432.Ccr-08-0872","volume":"14","author":"JS de Bono","year":"2008","unstructured":"de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302\u20139. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0872.","journal-title":"Clin Cancer Res"},{"issue":"6254","key":"533_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.aab0917","volume":"349","author":"DT Miyamoto","year":"2015","unstructured":"Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science. 2015;349(6254):1351\u20136. https:\/\/doi.org\/10.1126\/science.aab0917.","journal-title":"Science"},{"issue":"1","key":"533_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176\u201387. https:\/\/doi.org\/10.1016\/j.cell.2014.08.016.","journal-title":"Cell"},{"issue":"7618","key":"533_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature19328","volume":"537","author":"NV Jordan","year":"2016","unstructured":"Jordan NV, Bardia A, Wittner BS, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537(7618):102\u20136. https:\/\/doi.org\/10.1038\/nature19328.","journal-title":"Nature"},{"issue":"1","key":"533_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0021-9258(17)34997-9","volume":"166","author":"E Chargaff","year":"1946","unstructured":"Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J Biol Chem. 1946;166(1):189\u201397.","journal-title":"J Biol Chem"},{"issue":"3","key":"533_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0092-8674(83)90040-5","volume":"33","author":"BT Pan","year":"1983","unstructured":"Pan BT. Johnstone RM Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967\u201378. https:\/\/doi.org\/10.1016\/0092-8674(83)90040-5.","journal-title":"Cell"},{"issue":"3","key":"533_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","volume":"183","author":"G Raposo","year":"1996","unstructured":"Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ. Geuze HJ B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161\u201372. https:\/\/doi.org\/10.1084\/jem.183.3.1161.","journal-title":"J Exp Med"},{"issue":"6","key":"533_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ. L\u00f6tvall JO Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654\u20139. https:\/\/doi.org\/10.1038\/ncb1596.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"533_CR29","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J, W\u00fcrdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470\u20136. https:\/\/doi.org\/10.1038\/ncb1800.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"533_CR30","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1016\/j.ymthe.2025.07.016","volume":"33","author":"Y Gui","year":"2025","unstructured":"Gui Y, Peng M, Huang Y, Chen Z, Chen J, Xiao J, et al. Hou Y New insights into extracellular vesicles in metastatic cancer: From mechanisms to diagnostics and targeted therapies. Mol Ther. 2025;33(10):4731\u201347. https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.016.","journal-title":"Mol Ther"},{"issue":"5","key":"533_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3724\/sp.J.1123.2024.11004","volume":"43","author":"HY Wang","year":"2025","unstructured":"Wang HY, Xie PJ, Qiao XQ. Zhang LY [Typical strategy and research progress of efficient isolation methods of exosomes based on affinity interaction]. Se Pu. 2025;43(5):413\u201323. https:\/\/doi.org\/10.3724\/sp.J.1123.2024.11004.","journal-title":"Se Pu"},{"issue":"1","key":"533_CR32","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"533_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"BDP MicroRNAs","year":"2004","unstructured":"MicroRNAs BDP. genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5.","journal-title":"Cell"},{"issue":"5","key":"533_CR34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","volume":"75","author":"B Wightman","year":"1993","unstructured":"Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75(5):855\u201362. https:\/\/doi.org\/10.1016\/0092-8674(93)90530-4.","journal-title":"Cell"},{"issue":"4","key":"533_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259\u201369. https:\/\/doi.org\/10.1038\/nrc1840.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"533_CR36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrd3864","volume":"11","author":"E van Rooij","year":"2012","unstructured":"van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11(11):860\u201372. https:\/\/doi.org\/10.1038\/nrd3864.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"533_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","volume":"133","author":"E Junn","year":"2012","unstructured":"Junn E, Mouradian MM. MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther. 2012;133(2):142\u201350. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.10.002.","journal-title":"Pharmacol Ther"},{"issue":"30","key":"533_CR38","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513\u20138. https:\/\/doi.org\/10.1073\/pnas.0804549105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"533_CR39","doi-asserted-by":"publisher","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. https:\/\/doi.org\/10.7554\/eLife.05005.","DOI":"10.7554\/eLife.05005"},{"issue":"D1","key":"533_CR40","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155-d162. https:\/\/doi.org\/10.1093\/nar\/gky1141.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"533_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R. Slack FJ MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203\u201322. https:\/\/doi.org\/10.1038\/nrd.2016.246.","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"533_CR42","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1073\/pnas.81.17.5523","volume":"81","author":"V Pachnis","year":"1984","unstructured":"Pachnis V, Belayew A, Tilghman SM. Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci U S A. 1984;81(17):5523\u20137. https:\/\/doi.org\/10.1073\/pnas.81.17.5523.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6873","key":"533_CR43","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/415810a","volume":"415","author":"F Sleutels","year":"2002","unstructured":"Sleutels F, Zwart R. Barlow DP The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature. 2002;415(6873):810\u20133. https:\/\/doi.org\/10.1038\/415810a.","journal-title":"Nature"},{"issue":"6322","key":"533_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/351153a0","volume":"351","author":"MS Bartolomei","year":"1991","unstructured":"Bartolomei MS, Zemel S. Tilghman SM Parental imprinting of the mouse H19 gene. Nature. 1991;351(6322):153\u20135. https:\/\/doi.org\/10.1038\/351153a0.","journal-title":"Nature"},{"key":"533_CR45","doi-asserted-by":"publisher","unstructured":"An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374. https:\/\/doi.org\/10.1038\/nature11247.","DOI":"10.1038\/nature11247"},{"key":"533_CR46","doi-asserted-by":"publisher","unstructured":"Pennisi E Genomics. ENCODE project writes eulogy for junk DNA. Science. 2012;337(6099):1159, 1161. https:\/\/doi.org\/10.1126\/science.337.6099.1159.","DOI":"10.1126\/science.337.6099.1159"},{"issue":"7364","key":"533_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nature10398","volume":"477","author":"M Guttman","year":"2011","unstructured":"Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477(7364):295\u2013300. https:\/\/doi.org\/10.1038\/nature10398.","journal-title":"Nature"},{"key":"533_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2024.101961","volume":"75","author":"L Li","year":"2024","unstructured":"Li L, Gao Y, Yu B, Zhang J, Ma G. Jin X Role of LncRNA H19 in tumor progression and treatment. Mol Cell Probes. 2024;75:101961. https:\/\/doi.org\/10.1016\/j.mcp.2024.101961.","journal-title":"Mol Cell Probes"},{"issue":"3","key":"533_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41419-023-05710-6","volume":"14","author":"Z Qin","year":"2023","unstructured":"Qin Z, Zhang W, Liu S, Wang Y, Peng X. Jia L PVT1 inhibition stimulates anti-tumor immunity, prevents metastasis, and depletes cancer stem cells in squamous cell carcinoma. Cell Death Dis. 2023;14(3):187. https:\/\/doi.org\/10.1038\/s41419-023-05710-6.","journal-title":"Cell Death Dis"},{"issue":"1","key":"533_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12943-025-02415-6","volume":"24","author":"A Bitaraf","year":"2025","unstructured":"Bitaraf A, Zafarani A, Jahandideh P, Hakak-Zargar B, Haghi A, Asgaritarghi G. Babashah S MALAT1 as a molecular driver of tumor progression, immune evasion, and resistance to therapy. Mol Cancer. 2025;24(1):245. https:\/\/doi.org\/10.1186\/s12943-025-02415-6.","journal-title":"Mol Cancer"},{"issue":"28","key":"533_CR51","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2174\/0113816128257113230921035222","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang Y. Wen Y The Role of LncRNA NEAT1 in Gastric Cancer: Tumor Development and Potential Therapeutic Target. Curr Pharm Des. 2023;29(28):2213\u201322. https:\/\/doi.org\/10.2174\/0113816128257113230921035222.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"533_CR52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12031-021-01900-z","volume":"72","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Safari M, Taheri M. Samadian M Expression of Linear and Circular lncRNAs in Alzheimer\u2019s Disease. J Mol Neurosci. 2022;72(2):187\u2013200. https:\/\/doi.org\/10.1007\/s12031-021-01900-z.","journal-title":"J Mol Neurosci"},{"issue":"11","key":"533_CR53","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2174\/1567205013666160622112234","volume":"13","author":"P Riva","year":"2016","unstructured":"Riva P, Ratti A. Venturin M The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis. Curr Alzheimer Res. 2016;13(11):1219\u201331. https:\/\/doi.org\/10.2174\/1567205013666160622112234.","journal-title":"Curr Alzheimer Res"},{"key":"533_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031170","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21031170.","journal-title":"Int J Mol Sci"},{"key":"533_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2019.12.013","volume":"139","author":"Y Xu","year":"2020","unstructured":"Xu Y, Luo Y, Liang C. Zhang T LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p\/KLF4\/myocardin axis. J Mol Cell Cardiol. 2020;139:47\u201361. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.12.013.","journal-title":"J Mol Cell Cardiol"},{"key":"533_CR56","doi-asserted-by":"publisher","first-page":"1573723","DOI":"10.3389\/fcell.2025.1573723","volume":"13","author":"J Mou","year":"2025","unstructured":"Mou J, Luo C, Zhang W, Shao Y, Pei J, Chen Y, et al. Sun H LncRNA CHRF: molecular mechanisms and therapeutic potentials in cardiovascular diseases, cancers and fibrosis. Front Cell Dev Biol. 2025;13:1573723. https:\/\/doi.org\/10.3389\/fcell.2025.1573723.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"533_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL. Huarte M Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"533_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","volume":"42","author":"CF Bennett","year":"2019","unstructured":"Bennett CF, Krainer AR. Cleveland DW Antisense Oligonucleotide Therapies for Neurodegenerative Diseases. Annu Rev Neurosci. 2019;42:385\u2013406. https:\/\/doi.org\/10.1146\/annurev-neuro-070918-050501.","journal-title":"Annu Rev Neurosci"},{"issue":"8","key":"533_CR59","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrd.2018.93","volume":"17","author":"KD Warner","year":"2018","unstructured":"Warner KD, Hajdin CE, Weeks KM. Principles for targeting RNA with drug-like small molecules. Nat Rev Drug Discov. 2018;17(8):547\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.93.","journal-title":"Nat Rev Drug Discov"},{"issue":"7659","key":"533_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503. https:\/\/doi.org\/10.1038\/nature22341.","journal-title":"Nature"},{"issue":"12","key":"533_CR61","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1182\/blood-2008-06-159541","volume":"113","author":"GL Klement","year":"2009","unstructured":"Klement GL, Yip TT, Cassiola F, Kikuchi L, Cervi D, Podust V, et al. Platelets actively sequester angiogenesis regulators. Blood. 2009;113(12):2835\u201342. https:\/\/doi.org\/10.1182\/blood-2008-06-159541.","journal-title":"Blood"},{"key":"533_CR62","first-page":"237","volume":"39","author":"L Riess","year":"1872","unstructured":"Riess L. Zur pathologischen Anatomie des Blutes. Arch Anat Physiol Wissensch Medical. 1872;39:237\u201340.","journal-title":"Arch Anat Physiol Wissensch Medical"},{"key":"533_CR63","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","volume":"114","author":"J Levin","year":"1964","unstructured":"Levin J. Conley CL THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE. Arch Intern Med. 1964;114:497\u2013500. https:\/\/doi.org\/10.1001\/archinte.1964.03860100079008.","journal-title":"Arch Intern Med"},{"issue":"1","key":"533_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.61.1.46","volume":"61","author":"GJ Gasic","year":"1968","unstructured":"Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968;61(1):46\u201352. https:\/\/doi.org\/10.1073\/pnas.61.1.46.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"533_CR65","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2016-11-751099","volume":"130","author":"JV Michael","year":"2017","unstructured":"Michael JV, Wurtzel JGT, Mao GF, Rao AK, Kolpakov MA, Sabri A, et al. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood. 2017;130(5):567\u201380. https:\/\/doi.org\/10.1182\/blood-2016-11-751099.","journal-title":"Blood"},{"issue":"6","key":"533_CR66","first-page":"1295","volume":"59","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt B, Hafner M, Echtenacher B. M\u00e4nnel DN Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59(6):1295\u2013300.","journal-title":"Cancer Res"},{"issue":"3","key":"533_CR67","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","volume":"122","author":"MM Denis","year":"2005","unstructured":"Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005;122(3):379\u201391. https:\/\/doi.org\/10.1016\/j.cell.2005.06.015.","journal-title":"Cell"},{"key":"533_CR68","doi-asserted-by":"publisher","unstructured":"In 't Veld S, Arkani M, Post E, Antunes-Ferreira M, D'Ambrosi S, Vessies DCL, et al. Detection and localization of early- and late-stage cancers using platelet RNA. Cancer Cell. 2022;40(9):999\u20131009.e1006. https:\/\/doi.org\/10.1016\/j.ccell.2022.08.006.","DOI":"10.1016\/j.ccell.2022.08.006"},{"key":"533_CR69","doi-asserted-by":"publisher","unstructured":"Best MG, Sol N, In 't Veld S, Vancura A, Muller M, Niemeijer AN, et al. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. Cancer Cell. 2017;32(2):238\u2013252.e239. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.004.","DOI":"10.1016\/j.ccell.2017.07.004"},{"key":"533_CR70","doi-asserted-by":"publisher","unstructured":"Sol N, In 't Veld S, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, et al. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma. Cell Rep Med. 2020;1(7):100101. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100101.","DOI":"10.1016\/j.xcrm.2020.100101"},{"issue":"1","key":"533_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1935-5","volume":"21","author":"SL Amarasinghe","year":"2020","unstructured":"Amarasinghe SL, Su S, Dong X, Zappia L, Ritchie ME, Gouil Q. Opportunities and challenges in long-read sequencing data analysis. Genome Biol. 2020;21(1):30. https:\/\/doi.org\/10.1186\/s13059-020-1935-5.","journal-title":"Genome Biol"},{"issue":"5670","key":"533_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/bmj.3.5670.547","volume":"3","author":"MG Lewis","year":"1969","unstructured":"Lewis MG, Ikonopisov RL, Nairn RC, Phillips TM, Fairley GH, Bodenham DC. Alexander P Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J. 1969;3(5670):547\u201352. https:\/\/doi.org\/10.1136\/bmj.3.5670.547.","journal-title":"Br Med J"},{"issue":"4","key":"533_CR73","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1073\/pnas.60.4.1231","volume":"60","author":"IE Hellstr\u00f6m","year":"1968","unstructured":"Hellstr\u00f6m IE, Hellstr\u00f6m KE, Pierce GE. Bill AH Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A. 1968;60(4):1231\u20138. https:\/\/doi.org\/10.1073\/pnas.60.4.1231.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"533_CR74","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.2910300404","volume":"30","author":"LV Crawford","year":"1982","unstructured":"Crawford LV, Pim DC. Bulbrook RD Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer. 1982;30(4):403\u20138. https:\/\/doi.org\/10.1002\/ijc.2910300404.","journal-title":"Int J Cancer"},{"issue":"1","key":"533_CR75","first-page":"16","volume":"54","author":"ML Disis","year":"1994","unstructured":"Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, et al. Existent T-cell and antibody immunity to HER-2\/neu protein in patients with breast cancer. Cancer Res. 1994;54(1):16\u201320.","journal-title":"Cancer Res"},{"issue":"8","key":"533_CR76","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1084\/jem.187.8.1349","volume":"187","author":"E Stockert","year":"1998","unstructured":"Stockert E, J\u00e4ger E, Chen YT, Scanlan MJ, Gout I, Karbach J, et al. Old LJ A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med. 1998;187(8):1349\u201354. https:\/\/doi.org\/10.1084\/jem.187.8.1349.","journal-title":"J Exp Med"},{"issue":"3","key":"533_CR77","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ijc.2910630313","volume":"63","author":"F Brasseur","year":"1995","unstructured":"Brasseur F, Rimoldi D, Li\u00e9nard D, Leth\u00e9 B, Carrel S, Arienti F, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer. 1995;63(3):375\u201380. https:\/\/doi.org\/10.1002\/ijc.2910630313.","journal-title":"Int J Cancer"},{"issue":"25","key":"533_CR78","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","volume":"92","author":"U Sahin","year":"1995","unstructured":"Sahin U, T\u00fcreci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A. 1995;92(25):11810\u20133. https:\/\/doi.org\/10.1073\/pnas.92.25.11810.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"533_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2007.01.002","volume":"249","author":"CG Gunawardana","year":"2007","unstructured":"Gunawardana CG. Diamandis EP High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett. 2007;249(1):110\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2007.01.002.","journal-title":"Cancer Lett"},{"issue":"1","key":"533_CR80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/pr100686b","volume":"10","author":"KS Anderson","year":"2011","unstructured":"Anderson KS, Sibani S, Wallstrom G, Qiu J, Mendoza EA, Raphael J, et al. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res. 2011;10(1):85\u201396. https:\/\/doi.org\/10.1021\/pr100686b.","journal-title":"J Proteome Res"},{"key":"533_CR81","doi-asserted-by":"publisher","first-page":"1166894","DOI":"10.3389\/fonc.2023.1166894","volume":"13","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhang F, Jiang J, Zhao C, Zhu L, Liu C, et al. Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination. Front Oncol. 2023;13:1166894. https:\/\/doi.org\/10.3389\/fonc.2023.1166894.","journal-title":"Front Oncol"},{"issue":"1","key":"533_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00796-w","volume":"13","author":"D Ma","year":"2025","unstructured":"Ma D, Gao X, Wang L, Yin H, Feng L, Zhu Y. Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications. Biomark Res. 2025;13(1):89. https:\/\/doi.org\/10.1186\/s40364-025-00796-w.","journal-title":"Biomark Res"},{"key":"533_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2023.100135","volume":"3","author":"A Auwal","year":"2024","unstructured":"Auwal A, Hossain MM, Pronoy TUH, Rashel KM, Nurujjaman M, Lam AK. Islam F Clinical significance of genomic sequencing of circulating tumour cells (CTCs) in cancer. J Liq Biopsy. 2024;3:100135. https:\/\/doi.org\/10.1016\/j.jlb.2023.100135.","journal-title":"J Liq Biopsy"},{"key":"533_CR84","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2147\/ijn.S502591","volume":"20","author":"X Su","year":"2025","unstructured":"Su X, Wang H, Li Q. Chen Z Extracellular Vesicles: A Review of Their Therapeutic Potentials, Sources, Biodistribution, and Administration Routes. Int J Nanomedicine. 2025;20:3175\u201399. https:\/\/doi.org\/10.2147\/ijn.S502591.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"533_CR85","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s12951-025-03768-2","volume":"23","author":"B Li","year":"2025","unstructured":"Li B, Wu W, Xu W, Qian H. Ji C Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application. J Nanobiotechnology. 2025;23(1):678. https:\/\/doi.org\/10.1186\/s12951-025-03768-2.","journal-title":"J Nanobiotechnology"},{"issue":"16","key":"533_CR86","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.1073\/pnas.96.16.9236","volume":"96","author":"B Vogelstein","year":"1999","unstructured":"Vogelstein B. Kinzler KW Digital PCR. Proc Natl Acad Sci U S A. 1999;96(16):9236\u201341. https:\/\/doi.org\/10.1073\/pnas.96.16.9236.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"533_CR87","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1373\/clinchem.2008.113035","volume":"55","author":"CA Milbury","year":"2009","unstructured":"Milbury CA, Li J. Makrigiorgos GM PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem. 2009;55(4):632\u201340. https:\/\/doi.org\/10.1373\/clinchem.2008.113035.","journal-title":"Clin Chem"},{"issue":"7","key":"533_CR88","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","volume":"17","author":"CR Newton","year":"1989","unstructured":"Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989;17(7):2503\u201316. https:\/\/doi.org\/10.1093\/nar\/17.7.2503.","journal-title":"Nucleic Acids Res"},{"key":"533_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2025.343994","volume":"1354","author":"K Muneeswaran","year":"2025","unstructured":"Muneeswaran K, de Silva VA, Branavan U, Dayabandara M, Hanwella R. Chandrasekharan NV PCR-based SNP genotyping: A comprehensive comparison of methods for affordable and accurate detection of class IV mutations. Anal Chim Acta. 2025;1354:343994. https:\/\/doi.org\/10.1016\/j.aca.2025.343994.","journal-title":"Anal Chim Acta"},{"issue":"8","key":"533_CR90","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3779\/j.issn.1009-3419.2025.101.13","volume":"28","author":"J Shi","year":"2025","unstructured":"Shi J, Wang Y, Zheng J. Zhou J [Advances in Diagnosis and Targeted Therapy of KRASG12C Mutant Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2025;28(8):597\u2013611. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2025.101.13.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"4","key":"533_CR91","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3892\/etm.2015.2221","volume":"9","author":"BO Zhang","year":"2015","unstructured":"Zhang BO, Xu CW, Shao Y, Wang HT, Wu YF, Song YY, et al. Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation. Exp Ther Med. 2015;9(4):1383\u20138. https:\/\/doi.org\/10.3892\/etm.2015.2221.","journal-title":"Exp Ther Med"},{"issue":"1","key":"533_CR92","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cam4.978","volume":"6","author":"W Wang","year":"2017","unstructured":"Wang W, Song Z. Zhang Y A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance. Cancer Med. 2017;6(1):154\u201362. https:\/\/doi.org\/10.1002\/cam4.978.","journal-title":"Cancer Med"},{"issue":"40","key":"533_CR93","doi-asserted-by":"publisher","first-page":"67810","DOI":"10.18632\/oncotarget.18866","volume":"8","author":"J Gu","year":"2017","unstructured":"Gu J, Zang W, Liu B, Li L, Huang L, Li S, et al. Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study. Oncotarget. 2017;8(40):67810\u201320. https:\/\/doi.org\/10.18632\/oncotarget.18866.","journal-title":"Oncotarget"},{"issue":"3","key":"533_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248775","volume":"16","author":"P Ye","year":"2021","unstructured":"Ye P, Cai P, Xie J. Wei Y The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis. PLoS ONE. 2021;16(3):e0248775. https:\/\/doi.org\/10.1371\/journal.pone.0248775.","journal-title":"PLoS ONE"},{"issue":"7","key":"533_CR95","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1002\/jmv.26846","volume":"93","author":"AA Kojabad","year":"2021","unstructured":"Kojabad AA, Farzanehpour M, Galeh HEG, Dorostkar R, Jafarpour A, Bolandian M. Nodooshan MM Droplet digital PCR of viral DNA\/RNA, current progress, challenges, and future perspectives. J Med Virol. 2021;93(7):4182\u201397. https:\/\/doi.org\/10.1002\/jmv.26846.","journal-title":"J Med Virol"},{"key":"533_CR96","doi-asserted-by":"publisher","unstructured":"Mazaika E, Homsy J Digital Droplet PCR: CNV Analysis and Other Applications. Curr Protoc Hum Genet. 2014;82:7.24.21\u201327.24.13. https:\/\/doi.org\/10.1002\/0471142905.hg0724s82.","DOI":"10.1002\/0471142905.hg0724s82"},{"key":"533_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ymeth.2021.04.008","volume":"201","author":"S Long","year":"2022","unstructured":"Long S. In pursuit of sensitivity: Lessons learned from viral nucleic acid detection and quantification on the Raindance ddPCR platform. Methods. 2022;201:82\u201395. https:\/\/doi.org\/10.1016\/j.ymeth.2021.04.008.","journal-title":"Methods"},{"key":"533_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12061305","author":"S Galimberti","year":"2022","unstructured":"Galimberti S, Balducci S, Guerrini F, Del Re M, Cacciola R. Digital droplet PCR in hematologic malignancies: a new useful molecular tool. Diagnostics (Basel). 2022. https:\/\/doi.org\/10.3390\/diagnostics12061305.","journal-title":"Diagnostics (Basel)"},{"issue":"28","key":"533_CR99","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1200\/jco.2016.66.7162","volume":"34","author":"GR Oxnard","year":"2016","unstructured":"Oxnard GR, Thress KS, Alden RS, Lawrance R, Paweletz CP, Cantarini M, et al. J\u00e4nne PA Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2016;34(28):3375\u201382. https:\/\/doi.org\/10.1200\/jco.2016.66.7162.","journal-title":"J Clin Oncol"},{"issue":"11","key":"533_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23458","volume":"34","author":"X Li","year":"2020","unstructured":"Li X, Du H, Luo J, Ding W, Lai B, He J, et al. Zhang Y Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules. J Clin Lab Anal. 2020;34(11):e23458. https:\/\/doi.org\/10.1002\/jcla.23458.","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"533_CR101","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1373\/clinchem.2013.211045","volume":"59","author":"TC Dingle","year":"2013","unstructured":"Dingle TC, Sedlak RH, Cook L. Jerome KR Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances. Clin Chem. 2013;59(11):1670\u20132. https:\/\/doi.org\/10.1373\/clinchem.2013.211045.","journal-title":"Clin Chem"},{"key":"533_CR102","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-0716-4188-0_8","volume":"2865","author":"C Pott","year":"2025","unstructured":"Pott C, Br\u00fcggemann M, Ritgen M, van der Velden VHJ. van Dongen JJM MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR. Methods Mol Biol. 2025;2865:189\u2013219. https:\/\/doi.org\/10.1007\/978-1-0716-4188-0_8.","journal-title":"Methods Mol Biol"},{"issue":"7057","key":"533_CR103","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature03959","volume":"437","author":"M Margulies","year":"2005","unstructured":"Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437(7057):376\u201380. https:\/\/doi.org\/10.1038\/nature03959.","journal-title":"Nature"},{"issue":"10","key":"533_CR104","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nbt1486","volume":"26","author":"J Shendure","year":"2008","unstructured":"Shendure J. Ji H Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135\u201345. https:\/\/doi.org\/10.1038\/nbt1486.","journal-title":"Nat Biotechnol"},{"key":"533_CR105","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/251364","volume":"2012","author":"L Liu","year":"2012","unstructured":"Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Law M Comparison of next-generation sequencing systems. J Biomed Biotechnol. 2012;2012:251364. https:\/\/doi.org\/10.1155\/2012\/251364.","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"533_CR106","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","volume":"17","author":"S Goodwin","year":"2016","unstructured":"Goodwin S, McPherson JD. McCombie WR Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17(6):333\u201351. https:\/\/doi.org\/10.1038\/nrg.2016.49.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"533_CR107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES. Speicher MR Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71\u201388. https:\/\/doi.org\/10.1038\/s41576-018-0071-5.","journal-title":"Nat Rev Genet"},{"key":"533_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.706910","volume":"11","author":"J Wei","year":"2021","unstructured":"Wei J, Feng J, Weng Y, Xu Z, Jin Y, Wang P, et al. The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer. Front Oncol. 2021;11:706910. https:\/\/doi.org\/10.3389\/fonc.2021.706910.","journal-title":"Front Oncol"},{"issue":"9","key":"533_CR109","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41591-018-0134-3","volume":"24","author":"DR Gandara","year":"2018","unstructured":"Gandara DR, Paul SM, Kowanetz M, Schleifman E, Zou W, Li Y, et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nat Med. 2018;24(9):1441\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0134-3.","journal-title":"Nat Med"},{"issue":"8","key":"533_CR110","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaoncol.2025.1646","volume":"11","author":"J Ta\u00efeb","year":"2025","unstructured":"Ta\u00efeb J, Sullo FG, Lecanu A, Bourreau C, Barbier E, Gandini A, et al. Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial. JAMA Oncol. 2025;11(8):874\u201382. https:\/\/doi.org\/10.1001\/jamaoncol.2025.1646.","journal-title":"JAMA Oncol"},{"issue":"9","key":"533_CR111","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167\u201377. https:\/\/doi.org\/10.1016\/j.annonc.2021.05.806.","journal-title":"Ann Oncol"},{"issue":"12","key":"533_CR112","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","volume":"40","author":"A Jamshidi","year":"2022","unstructured":"Jamshidi A, Liu MC, Klein EA, Venn O, Hubbell E, Beausang JF, et al. Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer Cell. 2022;40(12):1537-1549.e1512. https:\/\/doi.org\/10.1016\/j.ccell.2022.10.022.","journal-title":"Cancer Cell"},{"issue":"11","key":"533_CR113","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jamaoncol.2018.2969","volume":"4","author":"GR Oxnard","year":"2018","unstructured":"Oxnard GR, Hu Y, Mileham KF, Husain H, Costa DB, Tracy P, et al. Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib. JAMA Oncol. 2018;4(11):1527\u201334. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2969.","journal-title":"JAMA Oncol"},{"key":"533_CR114","unstructured":"Illumina I. NovaSeq X Series Specification Sheet. 2024.Available from: https:\/\/www.illumina.com.cn\/content\/dam\/illumina-marketing\/apac\/china\/docs\/datasheet\/novaseq-x-series-specification-sheet-m-us-00197_20240130_CN.pdf. Accessed 24 Jun 2026."},{"key":"533_CR115","unstructured":"Element Biosciences I. AVITI System Performance Data. 2025.Available from: https:\/\/www.elementbiosciences.com\/hubfs\/element_biosciences_2025\/pdfs\/resources_pdf\/LT_00003_K_Element_AVITI_System_Specification_Sheet.pdf?hsLang=en. Accessed 24 Jun 2026."},{"key":"533_CR116","unstructured":"MGI Tech Co. L. DNBSEQ-T20\u00d72 Sequencing Platform Product Specifications. 2024.Available from: https:\/\/www.mgi-tech.com\/brochure.html?keyword=T20. Accessed 24 Jun 2026."},{"key":"533_CR117","unstructured":"Ultima Genomics I. UG 100 Sequencing Platform specification sheet. 2025.Available from: https:\/\/www.ultimagenomics.com\/products\/ug-100-sequencing-platform\/. Accessed 24 Jun 2026."},{"key":"533_CR118","unstructured":"Pacific Biosciences of California I. Revio System Technical Specifications and Product Brochure. 2024.Available from: https:\/\/www.pacb.com\/wp-content\/uploads\/Revio-brochure.pdf. Accessed 24 Jun 2026."},{"key":"533_CR119","unstructured":"Oxford Nanopore Technologies plc. PromethION 2 Integrated product flyer. 2026.Available from: https:\/\/a.storyblok.com\/f\/196663\/x\/0c117a06df\/flyer-promethion-2-integrated.pdf. Accessed 24 Jun 2026."},{"issue":"7","key":"533_CR120","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMc2112090","volume":"386","author":"JE Gorzynski","year":"2022","unstructured":"Gorzynski JE, Goenka SD, Shafin K, Jensen TD, Fisk DG, Grove ME, et al. Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting. N Engl J Med. 2022;386(7):700\u20132. https:\/\/doi.org\/10.1056\/NEJMc2112090.","journal-title":"N Engl J Med"},{"key":"533_CR121","doi-asserted-by":"publisher","unstructured":"Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012;4(154):154ra135. https:\/\/doi.org\/10.1126\/scitranslmed.3004041.","DOI":"10.1126\/scitranslmed.3004041"},{"issue":"3","key":"533_CR122","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nmeth.4577","volume":"15","author":"DR Garalde","year":"2018","unstructured":"Garalde DR, Snell EA, Jachimowicz D, Sipos B, Lloyd JH, Bruce M, et al. Highly parallel direct RNA sequencing on an array of nanopores. Nat Methods. 2018;15(3):201\u20136. https:\/\/doi.org\/10.1038\/nmeth.4577.","journal-title":"Nat Methods"},{"issue":"11","key":"533_CR123","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nbt.2705","volume":"31","author":"D Sharon","year":"2013","unstructured":"Sharon D, Tilgner H, Grubert F. Snyder M A single-molecule long-read survey of the human transcriptome. Nat Biotechnol. 2013;31(11):1009\u201314. https:\/\/doi.org\/10.1038\/nbt.2705.","journal-title":"Nat Biotechnol"},{"key":"533_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092258","author":"M Ili\u00e9","year":"2022","unstructured":"Ili\u00e9 M, Hofman V, Bontoux C, Heeke S, Lespinet-Fabre V, Bordone O, et al. Setting up an ultra-fast next-generation sequencing approach as reflex testing at diagnosis of non-squamous non-small cell lung cancer; experience of a single center (LPCE, Nice, France). Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14092258.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"533_CR125","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1080\/14737159.2016.1255144","volume":"16","author":"JF Swennenhuis","year":"2016","unstructured":"Swennenhuis JF, van Dalum G, Zeune LL. Terstappen LW Improving the Cell Search\u00ae system. Expert Rev Mol Diagn. 2016;16(12):1291\u2013305. https:\/\/doi.org\/10.1080\/14737159.2016.1255144.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"533_CR126","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12885-020-07059-x","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Wu G, Yang W, Wang X, Duan L, Niu L, et al. Prognostic value of circulating tumor cells detected with the Cell Search system in esophageal cancer patients: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):581. https:\/\/doi.org\/10.1186\/s12885-020-07059-x.","journal-title":"BMC Cancer"},{"issue":"10","key":"533_CR127","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius \u00c5, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54(10):1655\u201361. https:\/\/doi.org\/10.1515\/cclm-2015-1195.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"533_CR128","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"EH Thijssen","year":"2020","unstructured":"Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Nat Med. 2020;26(3):387\u201397. https:\/\/doi.org\/10.1038\/s41591-020-0762-2.","journal-title":"Nat Med"},{"key":"533_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.aca.2015.12.039","volume":"910","author":"L Chang","year":"2016","unstructured":"Chang L, Li J. Wang L Immuno-PCR: An ultrasensitive immunoassay for biomolecular detection. Anal Chim Acta. 2016;910:12\u201324. https:\/\/doi.org\/10.1016\/j.aca.2015.12.039.","journal-title":"Anal Chim Acta"},{"issue":"7","key":"533_CR130","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1021\/cr068083a","volume":"108","author":"W Miao","year":"2008","unstructured":"Miao W. Electrogenerated chemiluminescence and its biorelated applications. Chem Rev. 2008;108(7):2506\u201353. https:\/\/doi.org\/10.1021\/cr068083a.","journal-title":"Chem Rev"},{"issue":"12","key":"533_CR131","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1373\/clinchem.2008.105601","volume":"54","author":"CM Sturgeon","year":"2008","unstructured":"Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Br\u00fcnner N, Chan DW, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem. 2008;54(12):e11-79. https:\/\/doi.org\/10.1373\/clinchem.2008.105601.","journal-title":"Clin Chem"},{"issue":"11","key":"533_CR132","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1373\/clinchem.2012.192716","volume":"58","author":"FS Apple","year":"2012","unstructured":"Apple FS, Ler R. Murakami MM Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58(11):1574\u201381. https:\/\/doi.org\/10.1373\/clinchem.2012.192716.","journal-title":"Clin Chem"},{"key":"533_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, Bj\u00f6rkesten J, Assarsson E, Henriksson S, et al. Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis. Mol Cell Proteomics. 2021;20:100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168.","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"533_CR134","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1053\/j.gastro.2021.07.026","volume":"161","author":"D Bergemalm","year":"2021","unstructured":"Bergemalm D, Andersson E, Hultdin J, Eriksson C, Rush ST, Kalla R, et al. Systemic Inflammation in Preclinical Ulcerative Colitis. Gastroenterology. 2021;161(5):1526-1539.e1529. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.026.","journal-title":"Gastroenterology"},{"issue":"52","key":"533_CR135","doi-asserted-by":"publisher","first-page":"21083","DOI":"10.1073\/pnas.1320659110","volume":"110","author":"X Ni","year":"2013","unstructured":"Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z, et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A. 2013;110(52):21083\u20138. https:\/\/doi.org\/10.1073\/pnas.1320659110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"533_CR136","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s42003-025-07652-5","volume":"8","author":"EJ Northrop-Albrecht","year":"2025","unstructured":"Northrop-Albrecht EJ, Kim Y, Taylor WR, Majumder S, Kisiel JB. Lucien F The proteomic landscape of stool-derived extracellular vesicles in patients with pre-cancerous lesions and colorectal cancer. Commun Biol. 2025;8(1):228. https:\/\/doi.org\/10.1038\/s42003-025-07652-5.","journal-title":"Commun Biol"},{"issue":"5","key":"533_CR137","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/cyto.a.23764","volume":"95","author":"Y Gu","year":"2019","unstructured":"Gu Y, Zhang AC, Han Y, Li J, Chen C, Lo YH. Machine learning based real-time image-guided cell sorting and classification. Cytometry A. 2019;95(5):499\u2013509. https:\/\/doi.org\/10.1002\/cyto.a.23764.","journal-title":"Cytometry A"},{"issue":"2","key":"533_CR138","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2024.11.009","volume":"43","author":"C Alix-Panabi\u00e8res","year":"2025","unstructured":"Alix-Panabi\u00e8res C. Pantel K Advances in liquid biopsy: From exploration to practical application. Cancer Cell. 2025;43(2):161\u20135. https:\/\/doi.org\/10.1016\/j.ccell.2024.11.009.","journal-title":"Cancer Cell"},{"issue":"1","key":"533_CR139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","volume":"26","author":"GS Gulati","year":"2025","unstructured":"Gulati GS, D\u2019Silva JP, Liu Y, Wang L. Newman AM Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat Rev Mol Cell Biol. 2025;26(1):11\u201331. https:\/\/doi.org\/10.1038\/s41580-024-00768-2.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6119","key":"533_CR140","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339(6119):580\u20134. https:\/\/doi.org\/10.1126\/science.1228522.","journal-title":"Science"},{"issue":"7571","key":"533_CR141","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nature15260","volume":"526","author":"DA Lawson","year":"2015","unstructured":"Lawson DA, Bhakta NR, Kessenbrock K, Prummel KD, Yu Y, Takai K, et al. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature. 2015;526(7571):131\u20135. https:\/\/doi.org\/10.1038\/nature15260.","journal-title":"Nature"},{"issue":"7658","key":"533_CR142","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546(7658):431\u20135. https:\/\/doi.org\/10.1038\/nature22794.","journal-title":"Nature"},{"issue":"7798","key":"533_CR143","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","volume":"579","author":"TD Wu","year":"2020","unstructured":"Wu TD, Madireddi S, de Almeida PE, Banchereau R, Chen YJ, Chitre AS, et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020;579(7798):274\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2056-8.","journal-title":"Nature"},{"issue":"4","key":"533_CR144","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41571-020-00449-x","volume":"18","author":"SH Gohil","year":"2021","unstructured":"Gohil SH, Iorgulescu JB, Braun DA, Keskin DB. Livak KJ Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy. Nat Rev Clin Oncol. 2021;18(4):244\u201356. https:\/\/doi.org\/10.1038\/s41571-020-00449-x.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"533_CR145","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201010021","volume":"192","author":"M Yu","year":"2011","unstructured":"Yu M, Stott S, Toner M, Maheswaran S. Haber DA Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011;192(3):373\u201382. https:\/\/doi.org\/10.1083\/jcb.201010021.","journal-title":"J Cell Biol"},{"key":"533_CR146","doi-asserted-by":"publisher","DOI":"10.2174\/0118740707311249240604053619","author":"GM Desta","year":"2024","unstructured":"Desta GM, Birhanu AG. Single-cell RNA sequencing: current progresses and future perspectives. Open Biotechnol J. 2024. https:\/\/doi.org\/10.2174\/0118740707311249240604053619.","journal-title":"Open Biotechnol J"},{"issue":"8","key":"533_CR147","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1039\/c3cs35528d","volume":"42","author":"TAP Biosensors","year":"2013","unstructured":"Biosensors TAP. sense and sensibility. Chem Soc Rev. 2013;42(8):3184\u201396. https:\/\/doi.org\/10.1039\/c3cs35528d.","journal-title":"Chem Soc Rev"},{"key":"533_CR148","doi-asserted-by":"publisher","unstructured":"Lu C, Han J, Sun X, Yang G Electrochemical Detection and Point-of-Care Testing for Circulating Tumor Cells: Current Techniques and Future Potentials. Sensors (Basel). 2020;20(21). https:\/\/doi.org\/10.3390\/s20216073.","DOI":"10.3390\/s20216073"},{"issue":"13","key":"533_CR149","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1002\/anie.201005853","volume":"50","author":"S Wang","year":"2011","unstructured":"Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew Chem Int Ed Engl. 2011;50(13):3084\u20138. https:\/\/doi.org\/10.1002\/anie.201005853.","journal-title":"Angew Chem Int Ed Engl"},{"key":"533_CR150","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.aca.2020.04.009","volume":"1121","author":"ZO Uygun","year":"2020","unstructured":"Uygun ZO, Yeniay L. Gi Rgi NSF CRISPR-dCas9 powered impedimetric biosensor for label-free detection of circulating tumor DNAs. Anal Chim Acta. 2020;1121:35\u201341. https:\/\/doi.org\/10.1016\/j.aca.2020.04.009.","journal-title":"Anal Chim Acta"},{"issue":"12","key":"533_CR151","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1039\/d1an00436k","volume":"146","author":"C Pothipor","year":"2021","unstructured":"Pothipor C, Jakmunee J, Bamrungsap S. Ounnunkad K An electrochemical biosensor for simultaneous detection of breast cancer clinically related microRNAs based on a gold nanoparticles\/graphene quantum dots\/graphene oxide film. Analyst. 2021;146(12):4000\u20139. https:\/\/doi.org\/10.1039\/d1an00436k.","journal-title":"Analyst"},{"issue":"12","key":"533_CR152","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1039\/c2lc21204h","volume":"12","author":"CD Chin","year":"2012","unstructured":"Chin CD, Linder V. Sia SK Commercialization of microfluidic point-of-care diagnostic devices. Lab Chip. 2012;12(12):2118\u201334. https:\/\/doi.org\/10.1039\/c2lc21204h.","journal-title":"Lab Chip"},{"issue":"18","key":"533_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37964","volume":"10","author":"S Nashruddin","year":"2024","unstructured":"Nashruddin S, Salleh FHM, Yunus RM. Zaman HB Artificial intelligence-powered electrochemical sensor: Recent advances, challenges, and prospects. Heliyon. 2024;10(18):e37964. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37964.","journal-title":"Heliyon"},{"issue":"12","key":"533_CR154","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","volume":"25","author":"P Razavi","year":"2019","unstructured":"Razavi P, Li BT, Brown DN, Jung B, Hubbell E, Shen R, et al. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. Nat Med. 2019;25(12):1928\u201337. https:\/\/doi.org\/10.1038\/s41591-019-0652-7.","journal-title":"Nat Med"},{"issue":"12","key":"533_CR155","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1158\/1078-0432.Ccr-24-3747","volume":"31","author":"CP Paweletz","year":"2025","unstructured":"Paweletz CP, Urvalek A, Ha M, Garg K, Bence Lin A, Szpurka AM, et al. Janne PA Round-Robin Comparison of RET Rearrangement Detection in ctDNA: A Novel Method for Limited Clinical Samples. Clin Cancer Res. 2025;31(12):2406\u201312. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-3747.","journal-title":"Clin Cancer Res"},{"key":"533_CR156","doi-asserted-by":"publisher","first-page":"1334808","DOI":"10.3389\/fmolb.2024.1334808","volume":"11","author":"TP Nguyen Hoang","year":"2024","unstructured":"Nguyen Hoang TP, Nguyen TA, Tran NHB, Nguyen Hoang VA, Thi Dao HT, Tran VU, et al. Analytical validation and clinical utilization of K-4CARE\u2122: a comprehensive genomic profiling assay with personalized MRD detection. Front Mol Biosci. 2024;11:1334808. https:\/\/doi.org\/10.3389\/fmolb.2024.1334808.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"533_CR157","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.molmed.2020.12.011","volume":"27","author":"H Luo","year":"2021","unstructured":"Luo H, Wei W, Ye Z, Zheng J. Xu RH Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA. Trends Mol Med. 2021;27(5):482\u2013500. https:\/\/doi.org\/10.1016\/j.molmed.2020.12.011.","journal-title":"Trends Mol Med"},{"issue":"35","key":"533_CR158","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.2217\/fon-2022-1041","volume":"18","author":"HT Nguyen","year":"2022","unstructured":"Nguyen HT, Khoa Huynh LA, Nguyen TV, Tran DH, Thu Tran TT, Le Khang ND, et al. Multimodal analysis of ctDNA methylation and fragmentomic profiles enhances detection of nonmetastatic colorectal cancer. Future Oncol. 2022;18(35):3895\u2013912. https:\/\/doi.org\/10.2217\/fon-2022-1041.","journal-title":"Future Oncol"},{"issue":"10409","key":"533_CR159","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/s0140-6736(23)01700-2","volume":"402","author":"D Schrag","year":"2023","unstructured":"Schrag D, Beer TM, McDonnell CH 3rd, Nadauld L, Dilaveri CA, Reid R, et al. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402(10409):1251\u201360. https:\/\/doi.org\/10.1016\/s0140-6736(23)01700-2.","journal-title":"Lancet"},{"issue":"3","key":"533_CR160","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.clcc.2025.03.002","volume":"24","author":"SE Kim","year":"2025","unstructured":"Kim SE, Lee JS, Kim SY, Kim JE, Hong YS. Kim TW Prognostic Relevance of ctDNA RAS Mutation in Patients With Metastatic Colorectal Cancer Treated With Cetuximab. Clin Colorectal Cancer. 2025;24(3):341-351.e345. https:\/\/doi.org\/10.1016\/j.clcc.2025.03.002.","journal-title":"Clin Colorectal Cancer"},{"key":"533_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030413","author":"JV Machado Carvalho","year":"2023","unstructured":"Machado Carvalho JV, Dutoit V, Corr\u00f2 C, Koessler T. Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12030413.","journal-title":"Cells"},{"issue":"1","key":"533_CR162","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41467-024-46307-7","volume":"15","author":"B Chen","year":"2024","unstructured":"Chen B, Liu S, Zhu Y, Wang R, Cheng X, Chen B, et al. Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab. Nat Commun. 2024;15(1):1919. https:\/\/doi.org\/10.1038\/s41467-024-46307-7.","journal-title":"Nat Commun"},{"issue":"10","key":"533_CR163","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.3390\/curroncol30100643","volume":"30","author":"MI Koukourakis","year":"2023","unstructured":"Koukourakis MI, Xanthopoulou E, Koukourakis IM, Fortis SP, Kesesidis N, Kakouratos C, et al. Baxevanis CN Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Curr Oncol. 2023;30(10):8902\u201315. https:\/\/doi.org\/10.3390\/curroncol30100643.","journal-title":"Curr Oncol"},{"issue":"19","key":"533_CR164","doi-asserted-by":"publisher","first-page":"11067","DOI":"10.1093\/nar\/gkab871","volume":"49","author":"L Yang","year":"2021","unstructured":"Yang L, Shen C, Estrada-Bernal A, Robb R, Chatterjee M, Sebastian N, et al. Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair. Nucleic Acids Res. 2021;49(19):11067\u201382. https:\/\/doi.org\/10.1093\/nar\/gkab871.","journal-title":"Nucleic Acids Res"},{"issue":"7637","key":"533_CR165","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS. Mellman I Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321\u201330. https:\/\/doi.org\/10.1038\/nature21349.","journal-title":"Nature"},{"issue":"8","key":"533_CR166","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/annonc\/mdx212","volume":"28","author":"L Cabel","year":"2017","unstructured":"Cabel L, Riva F, Servois V, Livartowski A, Daniel C, Rampanou A, et al. Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. Ann Oncol. 2017;28(8):1996\u20132001. https:\/\/doi.org\/10.1093\/annonc\/mdx212.","journal-title":"Ann Oncol"},{"key":"533_CR167","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001504","author":"B Ricciuti","year":"2021","unstructured":"Ricciuti B, Jones G, Severgnini M, Alessi JV, Recondo G, Lawrence M, et al. Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC). J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2020-001504.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"533_CR168","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S. Bardelli A Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2017.14.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"533_CR169","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/1078-0432.Ccr-17-1341","volume":"24","author":"SB Goldberg","year":"2018","unstructured":"Goldberg SB, Narayan A, Kole AJ, Decker RH, Teysir J, Carriero NJ, et al. Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA. Clin Cancer Res. 2018;24(8):1872\u201380. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-1341.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"533_CR170","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nm.3870","volume":"21","author":"G Siravegna","year":"2015","unstructured":"Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21(7):795\u2013801. https:\/\/doi.org\/10.1038\/nm.3870.","journal-title":"Nat Med"},{"key":"533_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010087","author":"V Formica","year":"2020","unstructured":"Formica V, Lucchetti J, Doldo E, Riondino S, Morelli C, Argir\u00f2 R, et al. Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients-the importance of tissue\/plasma discordant cases. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm10010087.","journal-title":"J Clin Med"},{"key":"533_CR172","doi-asserted-by":"publisher","DOI":"10.1200\/po.17.00160","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Brannon AR, Ferris LA, Campbell CD, Lin JJ, Schultz KR, et al. Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA. JCO Precis Oncol. 2018. https:\/\/doi.org\/10.1200\/po.17.00160.","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"533_CR173","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Rosenfeld N Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223\u201338. https:\/\/doi.org\/10.1038\/nrc.2017.7.","journal-title":"Nat Rev Cancer"},{"issue":"7867","key":"533_CR174","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","volume":"595","author":"T Powles","year":"2021","unstructured":"Powles T, Assaf ZJ, Davarpanah N, Banchereau R, Szabados BE, Yuen KC, et al. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma. Nature. 2021;595(7867):432\u20137. https:\/\/doi.org\/10.1038\/s41586-021-03642-9.","journal-title":"Nature"},{"issue":"10","key":"533_CR175","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1113205.","journal-title":"N Engl J Med"},{"issue":"4","key":"533_CR176","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N. Swanton C Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017;168(4):613\u201328. https:\/\/doi.org\/10.1016\/j.cell.2017.01.018.","journal-title":"Cell"},{"issue":"4","key":"533_CR177","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/03008916221122554","volume":"109","author":"R D'Onofrio","year":"2023","unstructured":"D\u2019Onofrio R, Caputo F, Prampolini F, Spallanzani A, Gelsomino F, Bettelli S, et al. CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice. Tumori. 2023;109(4):387\u201393. https:\/\/doi.org\/10.1177\/03008916221122554.","journal-title":"Tumori"},{"issue":"7","key":"533_CR178","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827b","volume":"21","author":"G Siravegna","year":"2015","unstructured":"Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21(7):827. https:\/\/doi.org\/10.1038\/nm0715-827b.","journal-title":"Nat Med"},{"issue":"6127","key":"533_CR179","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr. Kinzler KW Cancer genome landscapes. Science. 2013;339(6127):1546\u201358. https:\/\/doi.org\/10.1126\/science.1235122.","journal-title":"Science"},{"key":"533_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13152570","author":"SS Jayashankar","year":"2023","unstructured":"Jayashankar SS, Nasaruddin ML, Hassan MF, Dasrilsyah RA, Shafiee MN, Ismail NAS, et al. Non-invasive prenatal testing (NIPT): reliability, challenges, and future directions. Diagnostics (Basel). 2023. https:\/\/doi.org\/10.3390\/diagnostics13152570.","journal-title":"Diagnostics (Basel)"},{"key":"533_CR181","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejogrb.2018.03.033","volume":"225","author":"B Renga","year":"2018","unstructured":"Renga B. Non invasive prenatal diagnosis of fetal aneuploidy using cell free fetal DNA. Eur J Obstet Gynecol Reprod Biol. 2018;225:5\u20138. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.033.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"533_CR182","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1471-0528.14050","volume":"124","author":"FL Mackie","year":"2017","unstructured":"Mackie FL, Hemming K, Allen S, Morris RK. Kilby MD The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG. 2017;124(1):32\u201346. https:\/\/doi.org\/10.1111\/1471-0528.14050.","journal-title":"BJOG"},{"issue":"4","key":"533_CR183","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/aog.0000000000004084","volume":"136","author":"Screening for Fetal Chromosomal Abnormalities","year":"2020","unstructured":"Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136(4):e48\u201369. https:\/\/doi.org\/10.1097\/aog.0000000000004084.","journal-title":"Obstet Gynecol"},{"issue":"7898","key":"533_CR184","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-022-04410-z","volume":"602","author":"MN Moufarrej","year":"2022","unstructured":"Moufarrej MN, Vorperian SK, Wong RJ, Campos AA, Quaintance CC, Sit RV, et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature. 2022;602(7898):689\u201394. https:\/\/doi.org\/10.1038\/s41586-022-04410-z.","journal-title":"Nature"},{"issue":"12","key":"533_CR185","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jama.2021.8551","volume":"326","author":"JT Henderson","year":"2021","unstructured":"Henderson JT, Vesco KK, Senger CA, Thomas RG. Redmond N Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;326(12):1192\u2013206. https:\/\/doi.org\/10.1001\/jama.2021.8551.","journal-title":"JAMA"},{"key":"533_CR186","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejogrb.2020.08.001","volume":"253","author":"E Scotchman","year":"2020","unstructured":"Scotchman E, Shaw J, Paternoster B, Chandler N, Chitty LS. Non-invasive prenatal diagnosis and screening for monogenic disorders. Eur J Obstet Gynecol Reprod Biol. 2020;253:320\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.08.001.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"533_CR187","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s43032-023-01301-0","volume":"31","author":"C Morales","year":"2024","unstructured":"Morales C. Current Applications and Controversies in Preimplantation Genetic Testing for Aneuploidies (PGT-A) in In Vitro Fertilization. Reprod Sci. 2024;31(1):66\u201380. https:\/\/doi.org\/10.1007\/s43032-023-01301-0.","journal-title":"Reprod Sci"},{"issue":"42","key":"533_CR188","doi-asserted-by":"publisher","first-page":"11907","DOI":"10.1073\/pnas.1613294113","volume":"113","author":"J Xu","year":"2016","unstructured":"Xu J, Fang R, Chen L, Chen D, Xiao JP, Yang W, et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc Natl Acad Sci U S A. 2016;113(42):11907\u201312. https:\/\/doi.org\/10.1073\/pnas.1613294113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"533_CR189","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5935\/1518-0557.20200075","volume":"24","author":"JG Franco Jr","year":"2020","unstructured":"Franco JG Jr, Dieamant F. Oliveira JBA Noninvasive preimplantation genetic testing for aneuploidies (niPGT-A) and the principle of primum non nocere. JBRA Assist Reprod. 2020;24(4):391\u20133. https:\/\/doi.org\/10.5935\/1518-0557.20200075.","journal-title":"JBRA Assist Reprod"},{"issue":"7","key":"533_CR190","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/asn.2016091034","volume":"28","author":"RD Bloom","year":"2017","unstructured":"Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, et al. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol. 2017;28(7):2221\u201332. https:\/\/doi.org\/10.1681\/asn.2016091034.","journal-title":"J Am Soc Nephrol"},{"key":"533_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/frtra.2025.1623514","volume":"4","author":"RK Bahniwal","year":"2025","unstructured":"Bahniwal RK, Mehta A, Kennedy JLW. Diagnostic approach to elevated dd-cfDNA with reassuring EMB in heart transplantation. Front Transplant. 2025;4:1623514. https:\/\/doi.org\/10.3389\/frtra.2025.1623514.","journal-title":"Front Transplant"},{"issue":"12","key":"533_CR192","doi-asserted-by":"publisher","DOI":"10.1097\/txd.0000000000001411","volume":"8","author":"AJ Trindade","year":"2022","unstructured":"Trindade AJ, Chapin KC, Mullican A, Gray JN, Hoy H, Demarest CT, et al. Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant. Transplant Direct. 2022;8(12):e1411. https:\/\/doi.org\/10.1097\/txd.0000000000001411.","journal-title":"Transplant Direct"},{"issue":"4","key":"533_CR193","doi-asserted-by":"publisher","DOI":"10.1097\/txd.0000000000001459","volume":"9","author":"A Yoo","year":"2023","unstructured":"Yoo A, Riedel A, Qian I, Bartosic A, Soltani R, Kibria G, et al. An initial analysis of the baseline levels of Dd-cfDNA after pancreas transplantation: a prospective study from high-volume centers in the United States. Transplant Direct. 2023;9(4):e1459. https:\/\/doi.org\/10.1097\/txd.0000000000001459.","journal-title":"Transplant Direct"},{"issue":"11","key":"533_CR194","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.healun.2021.05.012","volume":"40","author":"K Bazemore","year":"2021","unstructured":"Bazemore K, Rohly M, Permpalung N, Yu K, Timofte I, Brown AW, et al. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. J Heart Lung Transplant. 2021;40(11):1454\u201362. https:\/\/doi.org\/10.1016\/j.healun.2021.05.012.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"533_CR195","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14936","volume":"37","author":"B Boonpheng","year":"2023","unstructured":"Boonpheng B, De Castro ICC, Ng YH, Blosser C, Bakthavatsalam R, Gimferrer I, et al. Leca N Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients. Clin Transplant. 2023;37(5):e14936. https:\/\/doi.org\/10.1111\/ctr.14936.","journal-title":"Clin Transplant"},{"issue":"9","key":"533_CR196","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","volume":"17","author":"M Oellerich","year":"2021","unstructured":"Oellerich M, Sherwood K, Keown P, Sch\u00fctz E, Beck J, Stegbauer J, et al. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury. Nat Rev Nephrol. 2021;17(9):591\u2013603. https:\/\/doi.org\/10.1038\/s41581-021-00428-0.","journal-title":"Nat Rev Nephrol"},{"key":"533_CR197","doi-asserted-by":"publisher","first-page":"1574898","DOI":"10.3389\/frtra.2025.1574898","volume":"4","author":"Z Kattih","year":"2025","unstructured":"Kattih Z. Aryal S Using a combination of biomarkers to monitor allograft dysfunction in lung transplant recipients. Front Transplant. 2025;4:1574898. https:\/\/doi.org\/10.3389\/frtra.2025.1574898.","journal-title":"Front Transplant"},{"issue":"1","key":"533_CR198","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/alz.12166","volume":"17","author":"L Jia","year":"2021","unstructured":"Jia L, Zhu M, Kong C, Pang Y, Zhang H, Qiu Q, et al. Blood neuro-exosomal synaptic proteins predict Alzheimer\u2019s disease at the asymptomatic stage. Alzheimers Dement. 2021;17(1):49\u201360. https:\/\/doi.org\/10.1002\/alz.12166.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"533_CR199","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021;20(9):739\u201352. https:\/\/doi.org\/10.1016\/s1474-4422(21)00214-3.","journal-title":"Lancet Neurol"},{"issue":"8","key":"533_CR200","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772\u201381. https:\/\/doi.org\/10.1001\/jama.2020.12134.","journal-title":"JAMA"},{"issue":"13","key":"533_CR201","doi-asserted-by":"publisher","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","volume":"113","author":"R Lehmann-Werman","year":"2016","unstructured":"Lehmann-Werman R, Neiman D, Zemmour H, Moss J, Magenheim J, Vaknin-Dembinsky A, et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci U S A. 2016;113(13):E1826-1834. https:\/\/doi.org\/10.1073\/pnas.1519286113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"533_CR202","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamapsychiatry.2018.1725","volume":"75","author":"O Story Jovanova","year":"2018","unstructured":"Story Jovanova O, Nedeljkovic I, Spieler D, Walker RM, Liu C, Luciano M, et al. DNA methylation signatures of depressive symptoms in middle-aged and elderly persons: meta-analysis of multiethnic epigenome-wide studies. JAMA Psychiat. 2018;75(9):949\u201359. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.1725.","journal-title":"JAMA Psychiat"},{"issue":"9","key":"533_CR203","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.biopsych.2025.03.012","volume":"98","author":"D Wang","year":"2025","unstructured":"Wang D, Li D, Dang X, Mu C, Liu C, Zeng Y, et al. Mendelian randomization reveals causalities between DNA methylation and schizophrenia. Biol Psychiatry. 2025;98(9):712\u201323. https:\/\/doi.org\/10.1016\/j.biopsych.2025.03.012.","journal-title":"Biol Psychiatry"},{"key":"533_CR204","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-319-53889-1_12","volume":"978","author":"LK Pries","year":"2017","unstructured":"Pries LK, G\u00fcl\u00f6ks\u00fcz S. Kenis G DNA Methylation in Schizophrenia. Adv Exp Med Biol. 2017;978:211\u201336. https:\/\/doi.org\/10.1007\/978-3-319-53889-1_12.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"533_CR205","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1128\/jcm.00273-11","volume":"49","author":"J Yang","year":"2011","unstructured":"Yang J, Yang F, Ren L, Xiong Z, Wu Z, Dong J, et al. Unbiased parallel detection of viral pathogens in clinical samples by use of a metagenomic approach. J Clin Microbiol. 2011;49(10):3463\u20139. https:\/\/doi.org\/10.1128\/jcm.00273-11.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"533_CR206","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3201\/eid2101.140766","volume":"21","author":"C Kohl","year":"2015","unstructured":"Kohl C, Brinkmann A, Dabrowski PW, Radoni\u0107 A, Nitsche A. Kurth A Protocol for metagenomic virus detection in clinical specimens. Emerg Infect Dis. 2015;21(1):48\u201357. https:\/\/doi.org\/10.3201\/eid2101.140766.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"533_CR207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013381","volume":"5","author":"AL Greninger","year":"2010","unstructured":"Greninger AL, Chen EC, Sittler T, Scheinerman A, Roubinian N, Yu G, et al. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS ONE. 2010;5(10):e13381. https:\/\/doi.org\/10.1371\/journal.pone.0013381.","journal-title":"PLoS ONE"},{"key":"533_CR208","doi-asserted-by":"publisher","first-page":"1458316","DOI":"10.3389\/fcimb.2024.1458316","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang W. Zhang X Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases. Front Cell Infect Microbiol. 2024;14:1458316. https:\/\/doi.org\/10.3389\/fcimb.2024.1458316.","journal-title":"Front Cell Infect Microbiol"},{"key":"533_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2021.110235","volume":"117","author":"K Jiang","year":"2021","unstructured":"Jiang K, Jokhun DS. Lim CT Microfluidic detection of human diseases: From liquid biopsy to COVID-19 diagnosis. J Biomech. 2021;117:110235. https:\/\/doi.org\/10.1016\/j.jbiomech.2021.110235.","journal-title":"J Biomech"},{"key":"533_CR210","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16072","volume":"11","author":"K Hoeter","year":"2023","unstructured":"Hoeter K, Neuberger E, Fischer S, Herbst M, Ju\u0161kevi\u010di\u016bt\u0117 E, Enders K, et al. Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study. PeerJ. 2023;11:e16072. https:\/\/doi.org\/10.7717\/peerj.16072.","journal-title":"PeerJ"},{"issue":"6","key":"533_CR211","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058647","volume":"12","author":"D Dehnen","year":"2022","unstructured":"Dehnen D, Neuberger E. In der Schmitten J, Giagkou E, Simon P, Botzenhardt S cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study. BMJ Open. 2022;12(6):e058647. https:\/\/doi.org\/10.1136\/bmjopen-2021-058647.","journal-title":"BMJ Open"},{"issue":"4","key":"533_CR212","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ehjdh\/ztaf042","volume":"6","author":"R Poggio","year":"2025","unstructured":"Poggio R, Rodriguez-Granillo GA, De Lillo F, Rubilar AB, Garron-Arias SY, P\u00e9rez N, et al. Liquid biopsy based on whole blood transcriptome and artificial intelligence for the prediction of coronary artery calcification: a pilot study. Eur Heart J Digit Health. 2025;6(4):587\u201394. https:\/\/doi.org\/10.1093\/ehjdh\/ztaf042.","journal-title":"Eur Heart J Digit Health"},{"key":"533_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2025.200484","volume":"27","author":"S Rafiei","year":"2025","unstructured":"Rafiei S, Modarresi Chahardehi A. Lim V Circulating-free DNA: A promising tool for early detection of myocardial infarction. Int J Cardiol Cardiovasc Risk Prev. 2025;27:200484. https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200484.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"1","key":"533_CR214","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jmri.26716","volume":"51","author":"YN Zhang","year":"2020","unstructured":"Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, et al. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging. 2020;51(1):25\u201342. https:\/\/doi.org\/10.1002\/jmri.26716.","journal-title":"J Magn Reson Imaging"},{"key":"533_CR215","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","volume":"424","author":"H Yamada","year":"2013","unstructured":"Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, et al. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta. 2013;424:99\u2013103. https:\/\/doi.org\/10.1016\/j.cca.2013.05.021.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"533_CR216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142661","volume":"10","author":"PP Becker","year":"2015","unstructured":"Becker PP, Rau M, Schmitt J, Malsch C, Hammer C, Bantel H, et al. Geier A Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis. PLoS ONE. 2015;10(11):e0142661. https:\/\/doi.org\/10.1371\/journal.pone.0142661.","journal-title":"PLoS ONE"},{"issue":"5","key":"533_CR217","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","volume":"64","author":"CJ Pirola","year":"2015","unstructured":"Pirola CJ, Fern\u00e1ndez Gianotti T, Casta\u00f1o GO, Mallardi P, San Martino J, Mora Gonzalez Lopez Ledesma M, et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut. 2015;64(5):800\u201312. https:\/\/doi.org\/10.1136\/gutjnl-2014-306996.","journal-title":"Gut"},{"key":"533_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101581","volume":"65","author":"MY Hochreuter","year":"2022","unstructured":"Hochreuter MY, Dall M, Treebak JT. Barr\u00e8s R MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives. Mol Metab. 2022;65:101581. https:\/\/doi.org\/10.1016\/j.molmet.2022.101581.","journal-title":"Mol Metab"},{"issue":"6","key":"533_CR219","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22569","volume":"48","author":"O Cheung","year":"2008","unstructured":"Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 2008;48(6):1810\u201320. https:\/\/doi.org\/10.1002\/hep.22569.","journal-title":"Hepatology"},{"issue":"12","key":"533_CR220","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113651","volume":"9","author":"D Povero","year":"2014","unstructured":"Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A, et al. Feldstein AE Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS ONE. 2014;9(12):e113651. https:\/\/doi.org\/10.1371\/journal.pone.0113651.","journal-title":"PLoS ONE"},{"key":"533_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212229","author":"S Carpi","year":"2024","unstructured":"Carpi S, Daniele S, de Almeida JFM, Gabbia D. Recent advances in miRNA-based therapy for MASLD\/MASH and MASH-associated HCC. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252212229.","journal-title":"Int J Mol Sci"},{"key":"533_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101244","volume":"51","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhu Y, Hu S, Pan X, Bawa FC, Wang HH, et al. Zhang Y Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Mol Metab. 2021;51:101244. https:\/\/doi.org\/10.1016\/j.molmet.2021.101244.","journal-title":"Mol Metab"},{"issue":"1","key":"533_CR223","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1038\/s41598-021-94115-6","volume":"11","author":"TH Kim","year":"2021","unstructured":"Kim TH, Lee Y, Lee YS, Gim JA, Ko E, Yim SY, et al. Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease. Sci Rep. 2021;11(1):14639. https:\/\/doi.org\/10.1038\/s41598-021-94115-6.","journal-title":"Sci Rep"},{"issue":"8","key":"533_CR224","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105192","volume":"9","author":"Y Tan","year":"2014","unstructured":"Tan Y, Ge G, Pan T, Wen D. Gan J A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS ONE. 2014;9(8):e105192. https:\/\/doi.org\/10.1371\/journal.pone.0105192.","journal-title":"PLoS ONE"},{"issue":"1","key":"533_CR225","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/apt.70150","volume":"62","author":"GP Caviglia","year":"2025","unstructured":"Caviglia GP, Casalone E, Rosso C, Aneli S, Allione A, Carli F, et al. Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease. Aliment Pharmacol Ther. 2025;62(1):22\u201332. https:\/\/doi.org\/10.1111\/apt.70150.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"533_CR226","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1038\/s41598-021-85421-0","volume":"11","author":"P Huang","year":"2021","unstructured":"Huang P, Tu B, Liao HJ, Huang FZ, Li ZZ, Zhu KY, et al. Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease. Sci Rep. 2021;11(1):5886. https:\/\/doi.org\/10.1038\/s41598-021-85421-0.","journal-title":"Sci Rep"},{"key":"533_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030560","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Liu CH, Wu D, Jiang W, Zhang N, Tang H. LncRNA and circRNA in patients with non-alcoholic fatty liver disease: a systematic review. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13030560.","journal-title":"Biomolecules"},{"issue":"4","key":"533_CR228","first-page":"2593","volume":"14","author":"W Zhou","year":"2022","unstructured":"Zhou W. Qiu K The correlation between lncRNA NEAT1 and serum hepcidin in the peripheral blood of non-alcoholic fatty liver disease patients. Am J Transl Res. 2022;14(4):2593\u20139.","journal-title":"Am J Transl Res"},{"issue":"1","key":"533_CR229","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-021-04269-0","volume":"477","author":"MJ Hu","year":"2022","unstructured":"Hu MJ, Long M. Dai RJ Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p\/GRIA3. Mol Cell Biochem. 2022;477(1):191\u2013203. https:\/\/doi.org\/10.1007\/s11010-021-04269-0.","journal-title":"Mol Cell Biochem"},{"key":"533_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/life10100230","author":"JG Park","year":"2020","unstructured":"Park JG, Kim G, Jang SY, Lee YR, Lee E, Lee HW, et al. Plasma long noncoding RNA LeXis is a potential diagnostic marker for non-alcoholic steatohepatitis. Life. 2020. https:\/\/doi.org\/10.3390\/life10100230.","journal-title":"Life"},{"key":"533_CR231","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.858558","volume":"10","author":"J Xiang","year":"2022","unstructured":"Xiang J, Deng YY, Liu HX. Pu Y LncRNA MALAT1 Promotes PPAR\u03b1\/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206\/ARNT Axis. Front Bioeng Biotechnol. 2022;10:858558. https:\/\/doi.org\/10.3389\/fbioe.2022.858558.","journal-title":"Front Bioeng Biotechnol"},{"key":"533_CR232","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.trsl.2017.09.001","volume":"190","author":"F Leti","year":"2017","unstructured":"Leti F, Legendre C, Still CD, Chu X, Petrick A, Gerhard GS. DiStefano JK Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells. Transl Res. 2017;190:25-39.e21. https:\/\/doi.org\/10.1016\/j.trsl.2017.09.001.","journal-title":"Transl Res"},{"issue":"1","key":"533_CR233","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","volume":"183","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, et al. Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output. Cell. 2020;183(1):76-93.e22. https:\/\/doi.org\/10.1016\/j.cell.2020.08.009.","journal-title":"Cell"},{"issue":"4","key":"533_CR234","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12072-016-9729-2","volume":"10","author":"N Akuta","year":"2016","unstructured":"Akuta N, Kawamura Y, Suzuki F, Saitoh S, Arase Y, Kunimoto H, et al. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Hepatol Int. 2016;10(4):647\u201356. https:\/\/doi.org\/10.1007\/s12072-016-9729-2.","journal-title":"Hepatol Int"},{"issue":"4","key":"533_CR235","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s40618-024-02499-9","volume":"48","author":"AL Tobaruela-Resola","year":"2025","unstructured":"Tobaruela-Resola AL, Riezu-Boj JI, Milagro FI, Mogna-Pelaez P, Herrero JI, Elorz M, et al. Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention. J Endocrinol Invest. 2025;48(4):987\u20131003. https:\/\/doi.org\/10.1007\/s40618-024-02499-9.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"533_CR236","first-page":"1905","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Yang D, Wang B, Zeng Y. Li W The value of miRNAs in the prognosis of obese patients receiving bariatric surgery. Am J Transl Res. 2021;13(4):1905\u201314.","journal-title":"Am J Transl Res"},{"issue":"4","key":"533_CR237","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3748\/wjg.v30.i4.332","volume":"30","author":"YJ Li","year":"2024","unstructured":"Li YJ, Baumert BO, Stratakis N, Goodrich JA, Wu HT, He JX, et al. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World J Gastroenterol. 2024;30(4):332\u201345. https:\/\/doi.org\/10.3748\/wjg.v30.i4.332.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"533_CR238","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"533_CR239","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"533_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071202","author":"P Pallante","year":"2021","unstructured":"Pallante P, Malapelle U, Nacchio M, Sgariglia R, Galati D, Capitelli L, et al. Liquid biopsy is a promising tool for genetic testing in idiopathic pulmonary fibrosis. Diagnostics (Basel). 2021. https:\/\/doi.org\/10.3390\/diagnostics11071202.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"533_CR241","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06975-5","volume":"23","author":"W Cai","year":"2025","unstructured":"Cai W, Zhang H, Li Z, Cai M, Chen P, Guo N, et al. Potential biomarkers of idiopathic pulmonary fibrosis: metabonomics driven lipid profiling. J Transl Med. 2025;23(1):1010. https:\/\/doi.org\/10.1186\/s12967-025-06975-5.","journal-title":"J Transl Med"},{"key":"533_CR242","doi-asserted-by":"publisher","first-page":"1421657","DOI":"10.3389\/fphar.2024.1421657","volume":"15","author":"Q Guo","year":"2024","unstructured":"Guo Q, Qiao P, Wang J, Zhao L, Guo Z, Li X, et al. Zhang L Investigating the value of urinary biomarkers in relation to lupus nephritis histopathology: present insights and future prospects. Front Pharmacol. 2024;15:1421657. https:\/\/doi.org\/10.3389\/fphar.2024.1421657.","journal-title":"Front Pharmacol"},{"key":"533_CR243","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clim.2016.04.005","volume":"168","author":"E Scott","year":"2016","unstructured":"Scott E, Dooley MA, Vilen BJ. Clarke SH Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney. Clin Immunol. 2016;168:16\u201324. https:\/\/doi.org\/10.1016\/j.clim.2016.04.005.","journal-title":"Clin Immunol"},{"issue":"1","key":"533_CR244","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/cei.13050","volume":"191","author":"D Mesquita Jr","year":"2018","unstructured":"Mesquita D Jr, Kirsztajn GM, Franco MF, Reis LA, Perazzio SF, Mesquita FV, et al. de Souza AWS CD4(+) T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response? Clin Exp Immunol. 2018;191(1):50\u20139. https:\/\/doi.org\/10.1111\/cei.13050.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"533_CR245","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1097\/rhu.0000000000001553","volume":"27","author":"AA Abdelati","year":"2021","unstructured":"Abdelati AA, Eshak NY, Donia HM. El-Girby AH Urinary Cellular Profile as a Biomarker for Lupus Nephritis. J Clin Rheumatol. 2021;27(8):e469\u201376. https:\/\/doi.org\/10.1097\/rhu.0000000000001553.","journal-title":"J Clin Rheumatol"},{"key":"533_CR246","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000763","author":"E Weeding","year":"2022","unstructured":"Weeding E, Fava A, Mohan C, Magder L, Goldman D, Petri M. Urine proteomic insights from the belimumab in lupus nephritis trial. Lupus Sci Med. 2022. https:\/\/doi.org\/10.1136\/lupus-2022-000763.","journal-title":"Lupus Sci Med"},{"key":"533_CR247","doi-asserted-by":"publisher","unstructured":"H\u00e4yry A, Faustini F, Zickert A, Larsson A, Niewold TB, Svenungsson E, Oke V, Gunnarsson I Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. Lupus Sci Med. 2022;9(1). https:\/\/doi.org\/10.1136\/lupus-2022-000744.","DOI":"10.1136\/lupus-2022-000744"},{"issue":"Suppl 4","key":"533_CR248","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/nep.13151","volume":"22","author":"CC Szeto","year":"2017","unstructured":"Szeto CC. Urinary mRNA and lupus disease flare. Nephrology (Carlton). 2017;22(Suppl 4):27\u201330. https:\/\/doi.org\/10.1111\/nep.13151.","journal-title":"Nephrology (Carlton)"},{"issue":"40","key":"533_CR249","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000005037","volume":"95","author":"CY Wu","year":"2016","unstructured":"Wu CY, Yang HY, Yao TC, Liu SH. Huang JL Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients. Medicine (Baltimore). 2016;95(40):e5037. https:\/\/doi.org\/10.1097\/md.0000000000005037.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"533_CR250","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1681\/asn.2013121356","volume":"26","author":"J Menke","year":"2015","unstructured":"Menke J, Amann K, Cavagna L, Blettner M, Weinmann A, Schwarting A. Kelley VR Colony-stimulating factor-1: a potential biomarker for lupus nephritis. J Am Soc Nephrol. 2015;26(2):379\u201389. https:\/\/doi.org\/10.1681\/asn.2013121356.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"533_CR251","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00393-016-0184-1","volume":"77","author":"MN Salem","year":"2018","unstructured":"Salem MN, Taha HA. Abd El-Fattah El-Feqi M, Eesa NN, Mohamed RA Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis. Z Rheumatol. 2018;77(1):71\u20137. https:\/\/doi.org\/10.1007\/s00393-016-0184-1.","journal-title":"Z Rheumatol"},{"issue":"4","key":"533_CR252","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/cmr.00046-17","volume":"30","author":"J Sakai","year":"2017","unstructured":"Sakai J. Akkoyunlu M The Role of BAFF System Molecules in Host Response to Pathogens. Clin Microbiol Rev. 2017;30(4):991\u20131014. https:\/\/doi.org\/10.1128\/cmr.00046-17.","journal-title":"Clin Microbiol Rev"},{"key":"533_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100027","volume":"3","author":"D Aguirre-Valencia","year":"2020","unstructured":"Aguirre-Valencia D, R\u00edos-Serna LJ, Posso-Osorio I, Naranjo-Escobar J, L\u00f3pez D, Bedoya-Joaqui V, et al. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers. J Transl Autoimmun. 2020;3:100027. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100027.","journal-title":"J Transl Autoimmun"},{"issue":"11","key":"533_CR254","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/1756-185x.13197","volume":"20","author":"S Soliman","year":"2017","unstructured":"Soliman S, Mohamed FA, Ismail FM, Stanley S, Saxena R. Mohan C Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis. Int J Rheum Dis. 2017;20(11):1714\u201327. https:\/\/doi.org\/10.1111\/1756-185x.13197.","journal-title":"Int J Rheum Dis"},{"key":"533_CR255","doi-asserted-by":"publisher","unstructured":"Rahman A Can measuring urinary biomarkers improve the management of lupus nephritis? Arthritis Res Ther. 2012;14(6):127. https:\/\/doi.org\/10.1186\/ar4098.","DOI":"10.1186\/ar4098"},{"issue":"1","key":"533_CR256","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13075-020-02209-9","volume":"22","author":"H Ding","year":"2020","unstructured":"Ding H, Lin C, Cai J, Guo Q, Dai M, Mohan C. Shen N Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology. Arthritis Res Ther. 2020;22(1):122. https:\/\/doi.org\/10.1186\/s13075-020-02209-9.","journal-title":"Arthritis Res Ther"},{"key":"533_CR257","doi-asserted-by":"publisher","DOI":"10.1172\/jci147334","author":"SA Chalmers","year":"2022","unstructured":"Chalmers SA, Ayilam Ramachandran R, Garcia SJ, Der E, Herlitz L, Ampudia J, et al. The CD6\/ALCAM pathway promotes lupus nephritis via T cell-mediated responses. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/jci147334.","journal-title":"J Clin Invest"},{"issue":"4","key":"533_CR258","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/0961203317738226","volume":"27","author":"JA G\u00f3mez-Puerta","year":"2018","unstructured":"G\u00f3mez-Puerta JA, Ortiz-Reyes B, Urrego T, Vanegas-Garc\u00eda AL, Mu\u00f1oz CH, Gonz\u00e1lez LA, et al. V\u00e1squez G Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients. Lupus. 2018;27(4):637\u201346. https:\/\/doi.org\/10.1177\/0961203317738226.","journal-title":"Lupus"},{"issue":"1","key":"533_CR259","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pathophys.2014.12.003","volume":"22","author":"H Susianti","year":"2015","unstructured":"Susianti H, Iriane VM, Dharmanata S, Handono K, Widijanti A, Gunawan A. Kalim H Analysis of urinary TGF-\u03b21, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis. Pathophysiology. 2015;22(1):65\u201371. https:\/\/doi.org\/10.1016\/j.pathophys.2014.12.003.","journal-title":"Pathophysiology"},{"issue":"8","key":"533_CR260","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/0961203314526292","volume":"23","author":"Y Nozaki","year":"2014","unstructured":"Nozaki Y, Kinoshita K, Yano T, Shiga T, Hino S, Niki K, et al. Matsumura I Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis. Lupus. 2014;23(8):769\u201377. https:\/\/doi.org\/10.1177\/0961203314526292.","journal-title":"Lupus"},{"issue":"1","key":"533_CR261","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13075-022-02763-4","volume":"24","author":"H Ding","year":"2022","unstructured":"Ding H, Shen Y, Lin C, Qin L, He S, Dai M, et al. Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis. Arthritis Res Ther. 2022;24(1):77. https:\/\/doi.org\/10.1186\/s13075-022-02763-4.","journal-title":"Arthritis Res Ther"},{"key":"533_CR262","doi-asserted-by":"publisher","unstructured":"Mao Z, Tan Y, Yu F, Zhao M Discovery of NEU1 as a candidatedone. renal biomarker for proliferative lupus nephritis chronicity. Lupus Sci Med. 2021;8(1). https:\/\/doi.org\/10.1136\/lupus-2021-000569.","DOI":"10.1136\/lupus-2021-000569"},{"issue":"14","key":"533_CR263","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1177\/0961203316644331","volume":"25","author":"NR Jog","year":"2016","unstructured":"Jog NR, Blanco I, Lee I, Putterman C. Caricchio R Urinary high-mobility group box-1 associates specifically with lupus nephritis class V. Lupus. 2016;25(14):1551\u20137. https:\/\/doi.org\/10.1177\/0961203316644331.","journal-title":"Lupus"},{"issue":"2","key":"533_CR264","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/eji.201847747","volume":"49","author":"C Burbano","year":"2019","unstructured":"Burbano C, G\u00f3mez-Puerta JA, Mu\u00f1oz-Vahos C, Vanegas-Garc\u00eda A, Rojas M, V\u00e1squez G. Casta\u00f1o D HMGB1(+) microparticles present in urine are hallmarks of nephritis in patients with systemic lupus erythematosus. Eur J Immunol. 2019;49(2):323\u201335. https:\/\/doi.org\/10.1002\/eji.201847747.","journal-title":"Eur J Immunol"},{"issue":"11","key":"533_CR265","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.638","volume":"11","author":"OC Kwon","year":"2021","unstructured":"Kwon OC, Lee EJ, Yeom J, Hong S, Lee CK, Yoo B, et al. Kim YG Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis. Clin Transl Med. 2021;11(11):e638. https:\/\/doi.org\/10.1002\/ctm2.638.","journal-title":"Clin Transl Med"},{"issue":"1","key":"533_CR266","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.1038\/s41598-019-46601-1","volume":"9","author":"A S\u00e1nchez-Navarro","year":"2019","unstructured":"S\u00e1nchez-Navarro A, Mej\u00eda-Vilet JM, P\u00e9rez-Villalva R, Carrillo-P\u00e9rez DL, Marquina-Castillo B, Gamba G. Bobadilla NA SerpinA3 in the Early Recognition of Acute Kidney Injury to Chronic Kidney Disease (CKD) transition in the rat and its Potentiality in the Recognition of Patients with CKD. Sci Rep. 2019;9(1):10350. https:\/\/doi.org\/10.1038\/s41598-019-46601-1.","journal-title":"Sci Rep"},{"issue":"4","key":"533_CR267","doi-asserted-by":"publisher","first-page":"F425","DOI":"10.1152\/ajprenal.00099.2022","volume":"323","author":"M Mart\u00ednez-Rojas","year":"2022","unstructured":"Mart\u00ednez-Rojas M, S\u00e1nchez-Navarro A, Mejia-Vilet JM, P\u00e9rez-Villalva R, Uribe N, Bobadilla NA. Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis. Am J Physiol Renal Physiol. 2022;323(4):F425-f434. https:\/\/doi.org\/10.1152\/ajprenal.00099.2022.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"533_CR268","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000002520","volume":"95","author":"Y Pang","year":"2016","unstructured":"Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, et al. Zhao MH Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study. Medicine (Baltimore). 2016;95(3):e2520. https:\/\/doi.org\/10.1097\/md.0000000000002520.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"533_CR269","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1097\/ms9.0000000000002563","volume":"86","author":"SY Hong","year":"2024","unstructured":"Hong SY, Miao LT, Yang YY, Wang SG. Expression profiles of urine exosomal tRNA-derived small RNAs and their potential roles in calcium oxalate stone disease. Ann Med Surg (Lond). 2024;86(10):5802\u201310. https:\/\/doi.org\/10.1097\/ms9.0000000000002563.","journal-title":"Ann Med Surg (Lond)"},{"key":"533_CR270","doi-asserted-by":"publisher","unstructured":"Kalantari S, Chashmniam S, Nafar M, Zakeri Z, Parvin M Metabolomics approach reveals urine biomarkers and pathways associated with the pathogenesis of lupus nephritis. Iran J Basic Med Sci. 2019;22(11):1288\u20131295. https:\/\/doi.org\/10.22038\/ijbms.2019.38713.9178.","DOI":"10.22038\/ijbms.2019.38713.9178"},{"issue":"11","key":"533_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103355","volume":"24","author":"K Anekthanakul","year":"2021","unstructured":"Anekthanakul K, Manocheewa S, Chienwichai K, Poungsombat P, Limjiasahapong S, Wanichthanarak K, et al. Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker. iScience. 2021;24(11):103355. https:\/\/doi.org\/10.1016\/j.isci.2021.103355.","journal-title":"iScience"},{"issue":"7","key":"533_CR272","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1177\/0961203320918011","volume":"29","author":"S Ganguly","year":"2020","unstructured":"Ganguly S, Kumar U, Gupta N, Guleria A, Majumdar S, Phatak S, et al. Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis. Lupus. 2020;29(7):782\u20136. https:\/\/doi.org\/10.1177\/0961203320918011.","journal-title":"Lupus"},{"key":"533_CR273","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1077645","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Zhang X, Meng K, Sun Y, Shu R, Han Y, et al. Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis. Front Immunol. 2023;14:1077645. https:\/\/doi.org\/10.3389\/fimmu.2023.1077645.","journal-title":"Front Immunol"},{"issue":"9","key":"533_CR274","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/ndt\/gfv128","volume":"30","author":"C Sol\u00e9","year":"2015","unstructured":"Sol\u00e9 C, Cort\u00e9s-Hern\u00e1ndez J, Felip ML, Vidal M. Ordi-Ros J miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant. 2015;30(9):1488\u201396. https:\/\/doi.org\/10.1093\/ndt\/gfv128.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"533_CR275","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1373\/clinchem.2017.274175","volume":"63","author":"M Cardenas-Gonzalez","year":"2017","unstructured":"Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE, et al. Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clin Chem. 2017;63(9):1515\u201326. https:\/\/doi.org\/10.1373\/clinchem.2017.274175.","journal-title":"Clin Chem"},{"issue":"4","key":"533_CR276","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40620-020-00832-y","volume":"34","author":"J Perez-Hernandez","year":"2021","unstructured":"Perez-Hernandez J, Martinez-Arroyo O, Ortega A, Galera M, Solis-Salguero MA, Chaves FJ, et al. Cortes R Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. J Nephrol. 2021;34(4):1157\u201367. https:\/\/doi.org\/10.1007\/s40620-020-00832-y.","journal-title":"J Nephrol"},{"issue":"9","key":"533_CR277","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/art.39219","volume":"67","author":"P Costa-Reis","year":"2015","unstructured":"Costa-Reis P, Russo PA, Zhang Z, Colonna L, Maurer K, Gallucci S, et al. The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis. Arthritis Rheumatol. 2015;67(9):2415\u201326. https:\/\/doi.org\/10.1002\/art.39219.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"533_CR278","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2025.2534493","volume":"47","author":"Y Yu","year":"2025","unstructured":"Yu Y, Niu YY, Zhang YY, Yu C. Urinary long non-coding RNA GAS5 as a noninvasive diagnostic biomarker for renal fibrosis. Ren Fail. 2025;47(1):2534493. https:\/\/doi.org\/10.1080\/0886022x.2025.2534493.","journal-title":"Ren Fail"},{"key":"533_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105887","volume":"173","author":"DN Daraghmeh","year":"2021","unstructured":"Daraghmeh DN, King C, Wiese MD. A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis. Pharmacol Res. 2021;173:105887. https:\/\/doi.org\/10.1016\/j.phrs.2021.105887.","journal-title":"Pharmacol Res"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00533-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:02:36Z","timestamp":1788807756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00533-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":279,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00533-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"164"}}